Insider buying last 90 days
No open-market insider purchases were filed for MRSH in the last 90 days.
From Form 4 filings, dated to when each was filed.
Marsh moves this week on the launch of BrightPath, a new global retirement solution spanning six markets with $116 billion in AUM, aimed at building recurring fee income. BMO Capital also upgraded the stock to Outperform from Market Perform, setting a price target of $230, even as the broader analyst base still carries an average "hold" rating with a mean target around $206.19. The stock also touched a 52-week high of $201.91 during the week.
Marsh closes at $210.38, up 3.3%, sitting above both its 50-day ($183.13) and 200-day ($177.54) moving averages, with the 50-day above the 200-day. The GekkoIndex reads 45.6, placing it in the Neutral zone, down 5.1 points over five sessions. Price stands 9.7% above Gekko Fair Value of $191.83.
The next earnings date falls on 28 January 2027, 84 days out and beyond a typical 20-trading-day hold. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows, though one billionaire holder is recorded. Seasonally, the next 20 trading days have averaged a 3.8% gain over 5 years, rising in 5 of them. Analyst sentiment splits 7 buy, 8 hold, and 1 sell across 16 firms, with the current consensus target implying a -2.4% gap to price, worth noting alongside the fair-value spread.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Marsh scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Above 50 and 200-day
Close $210.38 is above the 50-day ($183.13) and 200-day ($177.54) averages, and the 50-day is above the 200-day.
See the chart45.6, Neutral
Reading 45.6 is in the Neutral zone.
See the GekkoIndex9.7% above
Price is 9.7% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 84 days
Next report Jan 28, 2027, 84 days away — outside a typical 20-trading-day hold.
See earnings+3.8% on average
From this point in the calendar, the next 20 trading days averaged +3.8% over 5 years, rising in 5 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Marsh closed at $210.38 on Nov 4, 2026, +18.8% over the past year, inside a 52-week range of $156.60 to $210.95.
Use the left and right arrow keys to read daily values.
Put MRSH on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Marsh provides professional advisory services covering risk, strategy, and workforce-related matters for clients seeking guidance in these areas. The company is best known as the parent of several advisory brands, including its own insurance brokerage operations, Guy Carpenter for reinsurance and risk work, Mercer for human resources and investment advice, and Oliver Wyman Group for management and economic consulting.
Operations are divided into two main segments. The Risk and Insurance Services segment handles risk management along with insurance and reinsurance brokerage, carried out mainly through the Marsh and Guy Carpenter brands. The Consulting segment covers health, retirement, talent, and investment consulting, plus management, economic, and brand advisory work, with Mercer and Oliver Wyman Group driving this side of the business. The firm employs roughly 65,000 full-time staff worldwide.
Marsh is headquartered in New York City. Its shares are listed on the NYSE under the ticker MRSH.
Marsh’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 45.6, in the Neutral zone, down 5.1 points over five sessions.
Down 5.1 points over five sessions.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 74 | +0.3% | +2.4% | ||
| Accumulation | 215 | +0.4% | +0.5% | ||
| Neutral (current zone) | 328 | 0.0% | −0.7% | ||
| Distribution | 76 | −1.2% | −1.2% | ||
| Selling | 4 | Too few readings yet | |||
Average MRSH share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Marsh trades 9.7% above Gekko Fair Value of $191.83, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Marsh shares are worth, recalculated every trading day.
$191.83
Gekko Fair Value, Nov 4, 2026
9.7% Overvalued
At the end of Aug 2026 the price was 4.5% below the estimate.
No open-market insider purchases were filed for Marsh, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for MRSH in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in MRSH were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Marsh has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds MRSH.
Marsh reports on Jan 28, 2027, before the open (84 days away), and beat the EPS estimate in 8 of its last 8 reports.
Jan 28, 2027
Expected before the open, 84 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 15, 2026 | $2.03 est $1.97 | $6.86B est $6.64B | +5.6% |
| Jul 21, 2026 | $2.96 est $2.88 | $7.40B est $7.28B | −3.4% |
| Apr 16, 2026 | $3.29 est $3.26 | $7.30B est $7.41B | +0.5% |
| Jan 29, 2026 | $2.12 est $1.97 | $6.60B est $6.56B | +5.6% |
| Oct 16, 2025 | $1.85 est $1.78 | $6.35B est $6.32B | −7.0% |
| Jul 17, 2025 | $2.45 est $2.41 | $6.97B est $6.94B | +0.1% |
| Apr 17, 2025 | $3.06 est $3.00 | $7.06B est $7.08B | −8.3% |
| Jan 30, 2025 | $1.87 est $1.76 | $6.07B est $5.96B | −1.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Marsh is $205.38, −2.4% from the last close, from 16 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 16 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 3 | BMO Capital | $230 | +9.3% |
| Oct 27 | Evercore ISI | $224 | +6.5% |
| Oct 26 | Roth MKM | $200 | −4.9% |
| Oct 23 | Cantor Fitzgerald | $228 | +8.4% |
| Oct 20 | UBS | $222 | +5.5% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Marsh averaged +3.8% across the last 5 years, rising in 5 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.3% | 5 of 5 |
| Next 10 trading days | +2.3% | 4 of 5 |
| Next 15 trading days | +3.3% | 5 of 5 |
| Next 20 trading days | +3.8% | 5 of 5 |
| Next 30 trading days | +0.8% | 3 of 5 |
For scale, MRSH’s typical 20-trading-day move in either direction is about 3.6%.
Marsh’s market cap is $100.4B, with a P/E ratio of 24 and revenue of $28.46B over the last twelve months.
Coverage of Marsh this week reads positive: 5 positive, 2 neutral and 0 negative headlines.
Marsh’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| AJGArthur J. Gallagher | Distribution | 8.0% above |
| AONAon | Distribution | 6.2% above |
| WTWWillis Towers Watson | Distribution | 0.2% above |
| BROBrown & Brown | Neutral | 5.6% above |
| RYANRyan Specialty | Distribution | 7.8% above |
| CRVLCorVel | Distribution | 16.2% above |
A peer links to its own page where one exists.
Marsh’s market cap is $100.4B at the Nov 4, 2026 close of $210.38, with 475.5M shares outstanding. The shares trade on a P/E ratio of 24.
The consensus analyst 12-month price target for Marsh is $205.38, −2.4% from the last close. Of the 16 firms that rated the stock in the last 90 days, 7 rate it a buy, 8 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Marsh is overvalued: the Nov 4, 2026 close of $210.38 is 9.7% above Gekko Fair Value of $191.83. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Marsh is expected to report on Jan 28, 2027, before the market opens (84 days away). Analysts expect earnings of $2.20 per share on revenue of $6.91B. Marsh beat the earnings estimate in 8 of its last 8 reports, moving 4% on average across the report.
Marsh’s 52-week high is $210.95 and its 52-week low is $156.60; it closed at $210.38 on Nov 4, 2026, +18.8% over the past year. Over the last five years the shares peaked at $248.00 on Apr 4, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.